Carbohydrates
Cell Signaling Technology Mono-Methyl Lysine mme-K Mul
Mono-Methyl Lysine [mme-K] MultiMab
Cell Signaling Technology Di-Methyl Lysine Motif dme-K
Di-Methyl Lysine Motif [dme-K] MultiMab
Cell Signaling Technology Tri-Methyl Lysine Motif tme-K
Tri-Methyl Lysine Motif [tme-K] (D1L1X) Rabbit mAb 100 ul
Cell Signaling Technology Carboxymethyl/Carboxyethyl Lys
Carboxymethyl/Carboxyethyl Lysine (E5C5H) Rabbit mAb 100 ul
Cayman Chemical 4oxo2Nonenal Fatty Acids and D
A lipid peroxidation product; actively modifies histidine and lysine residues on proteins and causes protein cross-linking
Cayman Chemical 4oxo2Nonenal Fatty Acids and D
A lipid peroxidation product; actively modifies histidine and lysine residues on proteins and causes protein cross-linking
Cayman Chemical 4oxo2Nonenal Fatty Acids and D
A lipid peroxidation product; actively modifies histidine and lysine residues on proteins and causes protein cross-linking
Cayman Chemical 4oxo2Nonenal Fatty Acids and D
A lipid peroxidation product; actively modifies histidine and lysine residues on proteins and causes protein cross-linking
Medchemexpress LLC Tak-418 hydrochloride | 1818252-53-7 | 99.8% | C17H25ClN2O2S | 10MG
TAK-418 is an orally active, CNS-penetrant inhibitor of lysine-specific demethylase 1 (LSD1/KDM1A) developed as a clinical candidate for neurodevelopmental and other central nervous system disorders. It is supplied as a research compound for in vitro and in vivo pharmacology, pharmacokinetics, and translational studies, with reported formula C17H25ClN2O2S and CAS 1818252-53-7.
- Selective LSD1 inhibition with reported low-nanomolar potency.
- Orally bioavailable and brain-penetrant for CNS studies.
- Suitable for in vitro and in vivo pharmacology.
- Available in small-mg research pack sizes for preclinical work.
- High reported purity for reproducible experimental results.
- Storage guidance supports long-term sample integrity.